Response to: Cytomegalovirus seropositivity is independently associated with cardiovascular disease in non-dialysis dependent chronic kidney disease

Research output: Contribution to journalArticlepeer-review

Standard

Response to: Cytomegalovirus seropositivity is independently associated with cardiovascular disease in non-dialysis dependent chronic kidney disease. / Karangizi, Alvin H K; Chanouzas, Dimitrios; Fenton, Anthony; Moss, Paul; Cockwell, Paul; Ferro, Charles J; Harper, Lorraine.

In: QJM: An International Journal of Medicine, Vol. 113, No. 9, 09.2020, p. 702-703.

Research output: Contribution to journalArticlepeer-review

Harvard

APA

Vancouver

Author

Karangizi, Alvin H K ; Chanouzas, Dimitrios ; Fenton, Anthony ; Moss, Paul ; Cockwell, Paul ; Ferro, Charles J ; Harper, Lorraine. / Response to: Cytomegalovirus seropositivity is independently associated with cardiovascular disease in non-dialysis dependent chronic kidney disease. In: QJM: An International Journal of Medicine. 2020 ; Vol. 113, No. 9. pp. 702-703.

Bibtex

@article{774af0b8f3e04900988a5938de1a2692,
title = "Response to: Cytomegalovirus seropositivity is independently associated with cardiovascular disease in non-dialysis dependent chronic kidney disease",
abstract = "Background: Cardiovascular disease (CVD) is the leading cause of early death in patients with chronic kidney disease (CKD). Previous work has described an association between Cytomegalovirus (CMV) seropositivity and CVD amongst patients with dialysis dependent end stage renal disease. Whether CMV seropositivity is associated with CVD in non-dialysis dependent CKD has not been established. Aim: Investigate whether past CMV infection is associated with prevalent CVD in patients with non-dialysis dependent CKD. Design: A retrospective observational study using the Renal Impairment in Secondary Care cohort, a study evaluating bio-clinical determinants of outcomes in patients with progressive CKD. Methods: We assayed cryopreserved serum samples collected at inception for anti-CMV IgG antibodies from 764 patients with stages 2 to 5 CKD (pre-dialysis) and investigated its relationship with prevalent CVD. Results: Median estimated glomerular filtration was 24 ml/min/1.73 m 2 (IQR 19-32). Sixty-eight percent of patients were CMV seropositive. CMV seropositivity was associated with older age, non-Caucasian ethnicity, diabetes and higher social deprivation index score. On univariable analysis, CMV seropositivity correlated with higher systolic blood pressure (P = 0.044), prevalent CVD (P < 0.001), ischaemic heart disease (P < 0.001) and cerebrovascular disease (P = 0.022). On multivariable analysis, CMV seropositive patients nearly twice as likely to have CVD compared to seronegative patients [Odds Ratio (OR) = 1.998, CI 1.231-3.242, P = 0.005]. Conclusions: In patients with non-dialysis CKD, CMV seropositivity is independently associated with a higher prevalence of CVD. ",
author = "Karangizi, {Alvin H K} and Dimitrios Chanouzas and Anthony Fenton and Paul Moss and Paul Cockwell and Ferro, {Charles J} and Lorraine Harper",
year = "2020",
month = sep,
doi = "10.1093/qjmed/hcaa195",
language = "English",
volume = "113",
pages = "702--703",
journal = "QJM: An International Journal of Medicine",
issn = "1460-2725",
publisher = "Oxford University Press",
number = "9",

}

RIS

TY - JOUR

T1 - Response to: Cytomegalovirus seropositivity is independently associated with cardiovascular disease in non-dialysis dependent chronic kidney disease

AU - Karangizi, Alvin H K

AU - Chanouzas, Dimitrios

AU - Fenton, Anthony

AU - Moss, Paul

AU - Cockwell, Paul

AU - Ferro, Charles J

AU - Harper, Lorraine

PY - 2020/9

Y1 - 2020/9

N2 - Background: Cardiovascular disease (CVD) is the leading cause of early death in patients with chronic kidney disease (CKD). Previous work has described an association between Cytomegalovirus (CMV) seropositivity and CVD amongst patients with dialysis dependent end stage renal disease. Whether CMV seropositivity is associated with CVD in non-dialysis dependent CKD has not been established. Aim: Investigate whether past CMV infection is associated with prevalent CVD in patients with non-dialysis dependent CKD. Design: A retrospective observational study using the Renal Impairment in Secondary Care cohort, a study evaluating bio-clinical determinants of outcomes in patients with progressive CKD. Methods: We assayed cryopreserved serum samples collected at inception for anti-CMV IgG antibodies from 764 patients with stages 2 to 5 CKD (pre-dialysis) and investigated its relationship with prevalent CVD. Results: Median estimated glomerular filtration was 24 ml/min/1.73 m 2 (IQR 19-32). Sixty-eight percent of patients were CMV seropositive. CMV seropositivity was associated with older age, non-Caucasian ethnicity, diabetes and higher social deprivation index score. On univariable analysis, CMV seropositivity correlated with higher systolic blood pressure (P = 0.044), prevalent CVD (P < 0.001), ischaemic heart disease (P < 0.001) and cerebrovascular disease (P = 0.022). On multivariable analysis, CMV seropositive patients nearly twice as likely to have CVD compared to seronegative patients [Odds Ratio (OR) = 1.998, CI 1.231-3.242, P = 0.005]. Conclusions: In patients with non-dialysis CKD, CMV seropositivity is independently associated with a higher prevalence of CVD.

AB - Background: Cardiovascular disease (CVD) is the leading cause of early death in patients with chronic kidney disease (CKD). Previous work has described an association between Cytomegalovirus (CMV) seropositivity and CVD amongst patients with dialysis dependent end stage renal disease. Whether CMV seropositivity is associated with CVD in non-dialysis dependent CKD has not been established. Aim: Investigate whether past CMV infection is associated with prevalent CVD in patients with non-dialysis dependent CKD. Design: A retrospective observational study using the Renal Impairment in Secondary Care cohort, a study evaluating bio-clinical determinants of outcomes in patients with progressive CKD. Methods: We assayed cryopreserved serum samples collected at inception for anti-CMV IgG antibodies from 764 patients with stages 2 to 5 CKD (pre-dialysis) and investigated its relationship with prevalent CVD. Results: Median estimated glomerular filtration was 24 ml/min/1.73 m 2 (IQR 19-32). Sixty-eight percent of patients were CMV seropositive. CMV seropositivity was associated with older age, non-Caucasian ethnicity, diabetes and higher social deprivation index score. On univariable analysis, CMV seropositivity correlated with higher systolic blood pressure (P = 0.044), prevalent CVD (P < 0.001), ischaemic heart disease (P < 0.001) and cerebrovascular disease (P = 0.022). On multivariable analysis, CMV seropositive patients nearly twice as likely to have CVD compared to seronegative patients [Odds Ratio (OR) = 1.998, CI 1.231-3.242, P = 0.005]. Conclusions: In patients with non-dialysis CKD, CMV seropositivity is independently associated with a higher prevalence of CVD.

U2 - 10.1093/qjmed/hcaa195

DO - 10.1093/qjmed/hcaa195

M3 - Article

C2 - 32531065

VL - 113

SP - 702

EP - 703

JO - QJM: An International Journal of Medicine

JF - QJM: An International Journal of Medicine

SN - 1460-2725

IS - 9

ER -